Skip to content

Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation

Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03108430
Acronym
PrevAsPI-Obs
Enrollment
91
Registered
2017-04-11
Start date
2016-11-18
Completion date
2023-03-01
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhalation Pneumonia, Risk Factor

Brief summary

Inhalation pneumonia (PI) is common in clinical practice but is rarely studied. For example, there are no data on the incidence of pneumonia after inhalation and risk factors or protective factors to develop one since it is known that anyone who inhaled does not necessarily develop an IP. There is no data on the benefit of treating inhalation by antibiotic therapy pre-emptively although this practice is common. In this context, this observational study wishes to take stock of the situation on the subject in order to determine what actions to implement to prevent IP.

Interventions

OTHERRisk factors and incidence of IP after inhalation

Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* In intensive care: Any intubated patient who presented: * It is a coma with GCS ≤ 12 without VAS protection, whatever the duration * Either a proven inhalation, defined by the presence in the VAS of gastric fluid or food * Either a suspected inhalation, defined by the extrahospital anamnesis * In medicine : * Any wrong way (defined by a reflex cough when taking food) * Coma without intubation, regardless of duration or depth

Exclusion criteria

* Patients with VAP

Design outcomes

Primary

MeasureTime frame
Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.1 day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026